Strategies of protection from nitric oxide toxicity in islet inflammation

Journal of Molecular Medicine

Volumn 77, Issue 1, 1999, Pages 40-44

  Rothe, H ^a   Kolb, H ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Heat shock protein 70; Interleukin 12; Nitric oxide; Poly (ADP ribose) polymerase; Th1 Th2 balance

Indexed keywords

CYTOKINE; HEAT SHOCK PROTEIN 70; INTERLEUKIN 12; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

CELL SURVIVAL; CONFERENCE PAPER; ENZYME REPRESSION; GENE EXPRESSION; HELPER CELL; INFLAMMATION; INFLAMMATORY CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; PANCREAS ISLET BETA CELL;

EID: 0033010281     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050298     Document Type: Conference Paper

References (51)

1. 1. Kolb-Bachofen V, Kolb H (1989) A role for macrophages in the pathogenesis of type I diabetes. Autoimmunity 3: 145-155
2. 2. Lee KU, Amano K, Yoon JW (1989) Evidence for initial involvement of macrophages in development of insulitis in NOD mice. Diabetes 37: 989-991
3. 3. Mandrup-Poulson T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielson JH (1996) Affinity-purified human interleukin-1 is cytotoxic to isolated islets of Langerhans. Diabetologia 29: 63-67
4. 4. Pukel C, Baquerizo H, Rabinovitch A (1988) Destruction of rat islet cell monolayers by cytokines: synergistic interactions of inteferon-gamma, tumor necrosis factor alpha, lymphotoxin and interleukin-1. Diabetes 37: 133-136
5. 5. Burkart V, Koike T, Brenner HH, Kolb H (1992) Oxygen radiacals generated by the enzyme xanthin oxidase lyse pancreatic islet cells in vitro. Diabetologia 35: 1028-1034
6. 6. Malaisse WJ, Malaisse-Lagae F, Sener A, Pipeleers DG (1982) Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proc. Natl Acad Sci USA 79: 927-930
7. 7. Kröncke KD, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H (1991) Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun 175: 752-758
8. 8. Kallmann B, Burkart V, Kröncke KD, Kolb-Bachofen V, Kolb H (1992) Toxicity of chemically generated nitric oxide towards pancreatic islet cells can be prevented by nicotinamide. Life Sci 51: 671-678
9. 9. Moncada S, Higgs EA (1991) Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest 21: 361-374
10. 10. Kröncke KD, Rodriguez ML, Kolb H, Kolb-Bachofen V (1992) Cytotoxicity of activated rat macrophages against syngeneic islet cells is arginine-dependent, correlates with citrulline and nitrite concentrations and is identical tolysis by the nitric oxide donor nitroprusside. Diabetologia 36: 17-24
11. 11. Kleemann R, Rothe H, Kolb-Bachofen V, Xie Q, Nathan C, Martin S, Kolb H (1993) Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS 328: 9-12
12. 12. Rothe H, Faust H, Schade U, Kleemann R, Bosse G, Hibino T, Martin S, Kolb H (1994) Acceleration of diabetes development in NOD mice by cyclophosphamide is associated with a shift from IL-4 to IFN-gamma production and with enhanced expression of inducible NO-synthase in pancreatic lesions. Diabetologia 37: 1154-1158
13. 13. Burkart V, Kolb H (1993) Protection of islet cells from inflammatory cell death in vitro. Clin Exp Immunol 93: 273-278
14. 14. Imai Y, Kolb H, Burkart V (1993) Nitric oxide production from macrophages is regulated by arachidonic acid metabolites. Biochem Biophys Res Commun 197: 105-109
15. 15. Burkart V, Imai Y, Kallmann B, Kolb H (1992) Cyclosporin A protects pancreatic islet cells from nitric oxide-dependent macrophage cytotoxicity. FEBS Lett 313: 56-58
16. 16. Bergemann L, Kröncke KD, Suschek C, Kolb H, Kolb-Bachofen V (1992) Cytotoxic action of IL-1β against pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129: 103-106
17. 17. Southern C, Schulster D, Green IG (1990) Inhibition of insulin secretion by interleukin 1β and tumor necrosis factor alpha via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 276: 42-44
18. 18. Corbett JA, Lancester JR, Sweetland MA, McDaniel ML (1991) Interleukin-1β induced formation of EPR-detectible iron-nitrosyl-complexes in islets of Langerhans. J Biol Chem 266: 21351-21254
19. 19. Kolb H, Kiesel U, Kröncke KD, Kolb-Bachofen V (1991) Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor. Life Sci 25: 213-217
20. 20. Lukic ML, Stosic-Grujicic S, Ostojic N, Chan WL, Liew FY (1991) Inhibition of nitric oxide generation effects the induction of diabetes by streptozotocin in mice. Biochem Biophys Res Commun 178: 913-920
21. 21. Papaccio G, Esposito V, Latronico MVG, Pisanti FA (1995) Administration of a nitric oxide synthase inhibitor does not suppress low-dose streptozotocin in mice. Biochem Biophys Res Commun 178: 913-919
22. 22. Holstad M, Sandler S (1993) Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycemia induced by multiple low dose streptozotocin injections in mice. Autoimmunity 15: 311-314
23. 23. Lindsay RM, Smith W, Rossiter SP (1995) Nw-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E rats. Diabetes 44: 356-361
24. 24. Wu G (1995) Nitric oxide synthesis and the effect of aminoguanidine and NG-mono-methyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB-rat. Diabetes 44: 360-365
25. 25. Bowman M, Simelli O, Look Z (1994) Pharacokinetic and therapeutic analysis of aminoguanidine (AG) in NOD mouse. Diabetes 43 [Suppl 1]: 235A
26. 26. Faust A, Kleemann R, Rothe H, Kolb H (1996) Role of macrophages and cytokines in B-cell death. In: Sharif (ed) Lessons from Animal Diabetes VI. Birkhäuser, Boston: 47-56
27. 27. Corbett JA, Mikhal A, Shimatzu J, Frederick K, Misko TP, McDaniel ML, Kanagawa O, Unanue ER (1993) Nitric oxide production in islets from non-obese diabetic mice: aminoguanidine-sensitive and -resistent stages in the immunological diabetes process. Proc Natl Acad Sci USA 90: 8992-8995
28. 28. Taylor-Robinson AW, Liew FY, Severn A, Xu D, McSorley SJ, Garside P, Padron J, Phillips RS (1994) Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol 24: 980-984
29. 29. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408-411
30. 30. Harding FA, McArtur JG, Gross JA, Raulet DH, Allison JP (1992) CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356: 607-609
31. 31. Vieira LQ, Hondowicz BD, Alfonso LCC, Wysocka M, Trinchieri G, Scott P (1994) Infection with Leishmania major induces IL-12 production in vivo. Immunol Lett 40: 157-161
32. 32. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L (1995) Interleukin-12 administration induces T helper type I cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181: 817-821
33. 33. Rothe H, Burkart V, Faust A, Kolb H (1996) Interleukin-gene expression is associated with rapid diabetes development in NOD mice. Diabetologia 39: 119-122
34. 34. Rothe H, Hartmann B, Geerlings P, Kolb H (1996) Interleukin-12 gene expression of macrophages is regulated by nitric oxide. Biochem Biophys Res Commun 224: 159-163
35. 35. Mattner F, Fischer S, Guckes S, Jin S, Kaulen H, Rüde E, and Germann T (1993) The interleukin-12 p40 subunit specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol 23: 2203-2208
36. 36. Gillessen S, Carvajal D, Ling P, Podlasky FJ, Stremlo DL, Familetti PC, Gubler U, Presky DH, Stern AS, Gately MK (1995) Mouse interleukin-12 p40 homodimer: a potent IL-12 antagonist. Eur J Immunol 25: 200-206
37. 37. Fehsel K, Janowy A, Sun Q, Burkart V, Hartmann B, Kolb H (1993) Iselt cell DNA is a target of inflammatory attack by nitric oxide. Diabetes 42: 496-500
38. 38. Delaney CA, Green MHL, Green IC (1993) Endogenous nitric oxide induced by interleukin-1β in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the 'comet' assay. FEBS Lett 333: 291-295
39. + depletion. Biochem Biophys Res Commun 199: 1270-1277
40. 40. Kallmann B, Burkart V, Kröncke KD, Kolb-Bachofen V, Kolb H (1992) Toxicity of chemically generated nitric oxide towards pancreatic islet cells can be prevented by nicotinamide. Life Sci 51: 671-678
41. 41. Pozzilli P, Andreani D (1993) The potential role of nicotinamide in the secondary prevention of IDDM. Diabetes/Metab Rev 9: 219-230
42. 42. Kenmochi T, Mullen Y, Miyamoto M, Stein E (1994) Protection of mouse islet isografts from early transplanation damage by nicotinamide treatment of recipients. Transplant Proc 26: 693
43. 43. Heller B, Wang ZQ, Wagner E, Radons J, Bürkle A, Fehsel K, Burkart V, Kolb H (1995) Inactivation of the poly-(ADP-ribose)-polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem 270: 11176-11180
44. 44. Bellmann K, Jäättelä M, Wissing D, Burkart V, Kolb H (1996) Heat shock protein hsp70 overexpression confers resitance against nitric oxide. FEBS Lett 391: 185-188
45. 45. Bellmann K, Wenz A, Radons J, Burkart V, Kleemann R, Kolb H (1995) Heat shock induces resistance in rat pancreatic islet cells against nitric oxide, oxygen radicals and streptozotocin toxicity in vitro. J Clin Invest 95: 2840-2845
46. 46. Bellmann K, Hui L, Radons J, Burkart V, Kolb H (1997) Low stress response enhances vulnerability of islet cells in diabetes prone BB rats. Diabetes 46:232-236
47. 47. Wachlin G, Heine L, Dunger A, Schmidt S (1995) Different heat shock response of pancreatic islets of young diabetes prone BB rats and diabetes resistent LEW rat. Autoimmunity 21: 25-29
48. 48. Faust A, Rothe H, Schade U, Kolb H (1996) Primary non-function of islet grafts in autoimmune diabetic NOD mice is prevented by treatment with IL-4 and IL-10. Transplantation 62: 648-652
49. 49. Rapaport MJ, Jaramillo A, Zipris D (1993) Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 178: 87-99
50. 50. Rothe H, O'Hara RM, Martin S, Kolb H (1997) Suppresion of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonost IL-12(p40)2. Diabetologia 40: 641-646
51. 51. Rothe H, Faust H, Schade U, Kleemann R, Bosse G, Hibino T, Martin S, Kolb H (1994) Acceleration of diabetes development in NOD mice by cyclophosphamide is associated with a shift from IL-4 to IFN-gamma production and with enhanced expression of inducible NO-synthase in pancreatic lesions. Diabetologia 37: 1154-1158